BridgeMD
New treatment option for Esophageal Cancer
Official title Perioperative Analgesia Modes in Minimally Invasive Esophagectomy
ClinicalTrials.gov ID: NCT05504265
What this study is testing
What is Preemptive flurbiprofen axetil?
Preemptive flurbiprofen axetil is an investigational medicine, being studied as a potential treatment for esophageal cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study was designed to compare analgesic efficacy and safety of different perioperative analgesic modes in minimally invasive esophagectomy for esophageal cancer.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- 18-75 years;
- Patients underwent laparoscopic and thoracoscopic or robotic-assisted minimally invasive esophagectomy ;
- Informed consent.
You likely can't join if
- Has a history of cholecystitis or urolithiasis within 3 months;
- Has a history of atherothrombosis (peripheral arterial disease), stroke, myocardial infarction;
- With lung diseases, such as pneumonia, atelectasis, emphysema, pulmonary bullae, etc;
- Preoperative cardiac function grade ≥ III or coronary artery stenosis;
- Preoperative indwelling of a thoracic drainage tube;
- Long-term heavy drinker(heavy drinking was defined as follows: for men, consuming more than 4 drinks on any day or more than 14 drinks per week; For...
See the full eligibility criteria
- 18-75 years;
- Patients underwent laparoscopic and thoracoscopic or robotic-assisted minimally invasive esophagectomy ;
- Informed consent.
- Has a history of cholecystitis or urolithiasis within 3 months;
- Has a history of atherothrombosis (peripheral arterial disease), stroke, myocardial infarction;
- With lung diseases, such as pneumonia, atelectasis, emphysema, pulmonary bullae, etc;
- Preoperative cardiac function grade ≥ III or coronary artery stenosis;
- Preoperative indwelling of a thoracic drainage tube;
- Long-term heavy drinker(heavy drinking was defined as follows: for men, consuming more than 4 drinks on any day or more than 14 drinks per week; For women, consuming more than 3 drinks on any day or more than 7 drinks...
- Opioid-tolerant patients(defined as those who have been taking, for a week or longer, at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily or an...
- With painful skin complications, such as rashes and blisters;
- Conversion to open surgery;
- The postoperative ventilation function was limited, or the duration of endotracheal intubation was more than 24h.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.